Newsletter | June 15, 2026

06.15.26 -- Immobilized Enzymes Promise Alternative To Cyanogen Bromide's Toxicity

SPONSOR

Webinar: Breaking the CLD Bottleneck: Generate Stable High-Producing Clones in 14 Weeks

Accelerating cell line development is critical as monoclonal antibody modalities grow more complex. In this webinar, Thermo Fisher Scientific explores how the Gibco™ CHOvantage™ GS CLD kit enables rapid generation of stable, high-producing CHO cell lines for mAbs, bispecific antibodies, and fusion proteins. Learn how the platform delivers scalable performance, high titers, and stability to help streamline development. Click here to learn more.

FOCUS ON UPSTREAM MANUFACTURING

Immobilized Enzymes Promise Alternative To Cyanogen Bromide's Toxicity

Proteases may be more expensive up front, but the benefits of cutting out a highly toxic substance quickly add up when disposal and environmental safety costs go down.

Automated T Cell Manufacturing From Start To Fill

Gain insight into how an automated, closed workflow can integrate T cell enrichment, activation, transduction, expansion, and formulation across fresh and frozen starting materials.

Deference To The Differences Between Fibroblasts And MSCs

What separates fibroblasts from MSCs when both express identical markers and differentiate into bone, fat, and cartilage? Molecular profiling reveals they exist on a functional spectrum of plasticity.

Making MSCs GMP: A Compliant Workflow

Generate GMP-compliant mesenchymal stem cells (MSCs) at scale with a closed, automated workflow. Learn how to optimize MSC harvest yields and ensure trilineage differentiation.

Providing Solutions In Titer, Host Cell Protein, And Scalability

By leveraging expertise across a global network and executing a streamlined, rapid technology transfer, see how we were able to enable a highly data-driven approach to clone selection.

mRNA Vaccines And Therapeutics: Current Trends And Perspectives

Delve into the advancements and transformative impact of mRNA vaccine technology on modern medicine and explore how this technology is revolutionizing healthcare for the future and beyond.

Unlock The Potential Of GPEx Lightning Accelerate Your HEK CLD

Discover how an advanced cell line development platform now supports HEK cells alongside CHO, enabling rapid, scalable production of complex biologics while saving up to 12 weeks on timelines.

Industrializing Cell Therapy With Perfusion

Find out how intensified perfusion strategies enable rapid, high‑density CAR‑T expansion, predictive scale‑down modeling, and efficient automated harvest, supporting shorter timelines and higher yields.

A Beginner's Guide To Sf9 Culture In Stirred-Tank Bioreactors

Read about the workflow steps for Sf9 cell expansion, virus preparation, and protein production in stirred-tank bioreactors, including GFP expression.

UPSTREAM MANUFACTURING SOLUTIONS

Your Global Network For Mammalian Cell Culture Manufacturing - Boehringer Ingelheim Biopharmaceuticals GmbH

Is Your Current AAV Process Holding You Back? - Mirus Bio

Discover A Platform For Antibodies With Increased ADCC Activity - ATUM

Connect With Bioprocess Online: